Journal
JOURNAL OF CROHNS & COLITIS
Volume 2, Issue 4, Pages 291-295Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.crohns.2008.05.004
Keywords
Th17; IL-17; IL-23; Inflammatory bowel disease (IBD); Crohn's disease; Ulcerative colitis
Categories
Funding
- Fondazione Umberto di Mario, Rome
- Broad Medical Research Program Foundation [IBD-0154R]
- Giuliani SpA, Milan, Italy
Ask authors/readers for more resources
Although traditionally associated with exaggerated Th1 or Th2 cell response, the gut inflammation occurring in patients with IBD is also characterized by production of cytokines made by a distinct lineage of T helper cells, termed Th17 cells. The discovery that this new inflammatory T-cell subset drives immune-mediated pathology and that the antigen-presenting cell-derived IL-23 is necessary for amplifying Th17 cell-associated inflammation has contributed to elucidate new pathways of intestinal tissue damage as well as to open new avenues for development of therapeutic strategies in IBD. In this review, we discuss the available data regarding the involvement of Th17 cells and their interplay with other mucosal cell types in the modulation of intestinal tissue inflammation. (C) 2008 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available